Effects of NLRP3 Inflammasome Mediated Pyroptosis on Cardiovascular Diseases and Intervention Mechanism of Chinese Medicine

被引:0
|
作者
Yi Zhong
Xin-yue Li
Tian-jun Liang
Bao-zhu Ding
Ke-xin Ma
Wen-xuan Ren
Wen-jie Liang
机构
[1] Hebei University of Chinese Medicine,College of Integrated Traditional Chinese and Western Medicine
[2] Hebei Key Laboratory of Integrated Traditional Chinese and Western Medicine in Liver and Kidney Diseases,Department of Cardiovascular Internal Medicine
[3] Institute of Integrated Traditional Chinese and Western Medicine,Graduate School
[4] the Second Affiliated Hospital of Jiujiang University,Rural Physician College
[5] Hebei Medical University,Medical Department
[6] Hebei Medical University,undefined
[7] the First Hospital of Hebei Medical University,undefined
来源
Chinese Journal of Integrative Medicine | 2024年 / 30卷
关键词
pyroptosis; cardiovascular diseases; Chinese medicine; NOD-like receptor protein 3; mechanisms;
D O I
暂无
中图分类号
学科分类号
摘要
Activation of the NOD-like receptor protein 3 (NLRP3) inflammasome signaling pathway is an important mechanism underlying myocardial pyroptosis and plays an important role in inflammatory damage to myocardial tissue in patients with cardiovascular diseases (CVDs), such as diabetic cardiomyopathy, ischemia/reperfusion injury, myocardial infarction, heart failure and hypertension. Noncoding RNAs (ncRNAs) are important regulatory factors. Many Chinese medicine (CM) compounds, including their effective components, can regulate pyroptosis and exert myocardium-protecting effects. The mechanisms underlying this protection include inhibition of inflammasome protein expression, Toll-like receptor 4–NF-κB signal pathway activation, oxidative stress, endoplasmic reticulum stress (ERS), and mixed lineage kinase 3 expression and the regulation of silent information regulator 1. The NLRP3 protein is an important regulatory target for CVD prevention and treatment with CM. Exploring the effects of the interventions mediated by CM and the related mechanisms provides new ideas and perspectives for CVD prevention and treatment.
引用
收藏
页码:468 / 479
页数:11
相关论文
共 50 条
  • [1] Effects of NLRP3 Inflammasome Mediated Pyroptosis on Cardiovascular Diseases and Intervention Mechanism of Chinese Medicine
    Zhong, Yi
    Li, Xin-yue
    Liang, Tian-jun
    Ding, Bao-zhu
    Ma, Ke-xin
    Ren, Wen-xuan
    Liang, Wen-jie
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (05) : 468 - 479
  • [2] Effects of NLRP3 Inflammasome Mediated Pyroptosis on Cardiovascular Diseases and Intervention Mechanism of Chinese Medicine
    ZHONG Yi
    LI Xin-yue
    LIANG Tian-jun
    DING Bao-zhu
    MA Ke-xin
    REN Wen-xuan
    LIANG Wen-jie
    Chinese Journal of Integrative Medicine, 2024, (05) : 468 - 479
  • [3] NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention
    Ding, Ping
    Song, Yuanming
    Yang, Yang
    Zeng, Cheng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
    Toldo, Stefano
    Abbate, Antonio
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (04) : 219 - 237
  • [5] The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
    Stefano Toldo
    Antonio Abbate
    Nature Reviews Cardiology, 2024, 21 : 219 - 237
  • [6] The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine
    Long, Jia-Xin
    Tian, Meng-Zhi
    Chen, Xiao-Yi
    Yu, Huang-He
    Ding, Huang
    Liu, Fang
    Du, Ke
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] NLRP3 inflammasome as a mechanism linking depression and cardiovascular diseases
    Robert M. Carney
    Kenneth E. Freedland
    Nature Reviews Cardiology, 2017, 14 : 124 - 124
  • [8] Targeting the NLRP3 inflammasome in cardiovascular diseases
    Toldo, Stefano
    Mezzaroma, Eleonora
    Buckley, Leo F.
    Potere, Nicola
    Di Nisio, Marcello
    Biondi-Zoccai, Giuseppe
    Van Tassell, Benjamin W.
    Abbate, Antonio
    PHARMACOLOGY & THERAPEUTICS, 2022, 236
  • [9] NLRP3 inflammasome in cardiovascular diseases: an update
    Mo, Binhai
    Ding, Yudi
    Ji, Qingwei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [10] NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
    Mezzaroma, Eleonora
    Abbate, Antonio
    Toldo, Stefano
    MOLECULES, 2021, 26 (04):